Company profile
Specialist in treatment of iron deficiency anaemia and clinical grade dextran biopolymers
Pharmacosmos is a privately-owned, specialist pharmaceutical
company established in 1965 by Dr. Henry M. Christensen M.D. and is
specialized in:
- Treatment of iron deficiency anaemia in humans
- Treatment of iron deficiency anaemia in animals
- High quality, clinical grade dextran biopolymers
Our corporate headquarter is located in Denmark, Scandinavia,
where we manufacture and develop treatments of iron deficiency
anemia in humans and animals.
Specialist in iron therapy
A leading specialist in intravenous iron therapy, we market our
pharmaceuticals products for treatment of iron deficiency anaemia,
Monofer® (iron isomaltoside 1000) and
Cosmofer® (low molecular weight iron dextran), in more than 45
countries worldwide.
Our veterinary product,
Uniferon® (iron dextran) is the only treatment and prevention
of iron deficiency in animals approved by health authorities in
Europe, Asia and by FDA in the US.
Clinical grade dextran biopolymers
Our second focus area, Pharmacosmos is the leading manufacturer
of high quality, clinical grade dextran biopolymers.
Learn more about our products for treatments
of iron deficiency anaemia and
clinical grade dextran biopolymers.
Or read about Pharmacosmos Board of Directors.